Status:

COMPLETED

Reducing Total Cardiovascular Risk in an Urban Community

Lead Sponsor:

Johns Hopkins University

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Cardiovascular Diseases

Heart Diseases

Eligibility:

All Genders

21-80 years

Phase:

PHASE4

Brief Summary

PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effective...

Detailed Description

BACKGROUND: The study is based on the premise that a community-based participatory research partnership model, using a team of an advanced practice nurse case manager, community health worker (CHW), ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Currently receiving medical care at Johns Hopkins University
  • African American or Caucasian and have diagnosed CVD, defined as a prior myocardial infarction, revascularization procedure for coronary disease, ischemic heart disease, stroke, or have diagnosed type 2 diabetes and not receiving any therapy
  • Have either no LDL-C in their medical record during the 12 months prior to study entry or have an LDL greater than or equal to 100 mg/dl on or off lipid lowering pharmacotherapy
  • Have either no blood pressure recorded in their medical record during the 12 months prior to study entry or a BP greater than 140/90 mmHg or greater than 130/80 mmHg if the participant is diabetic or has renal insufficiency
  • If the participant is diabetic he or she has to either have no HbA1c recorded during the 12 months prior to study entry or HbA1c of 7 percent or greater
  • Exclusion criteria:
  • A serious life-threatening noncardiac comorbidity with a life expectancy of less than 5 years
  • A serious physician-recorded psychiatric morbidity that would interfere with the study
  • Sufficient neurological impairment that would interfere with the study

Exclusion

    Key Trial Info

    Start Date :

    May 1 2006

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    May 1 2010

    Estimated Enrollment :

    525 Patients enrolled

    Trial Details

    Trial ID

    NCT00241904

    Start Date

    May 1 2006

    End Date

    May 1 2010

    Last Update

    September 15 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Johns Hopkins University

    Baltimore, Maryland, United States, 21205